Holen Sie sich die Stockscreener-App
85.31
2.60%
2.16
Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten
Hsbc Holdings PLC Reduces Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Incorporated $CORT Shares Sold by American Century Companies Inc. - MarketBeat
Epoch Investment Partners Inc. Invests $56.18 Million in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept, Optime file reply for dismissing Teva's US antitrust claims - MLex
Kennedy Capital Management LLC Raises Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Norges Bank Makes New Investment in Corcept Therapeutics Incorporated $CORT - MarketBeat
State Board of Administration of Florida Retirement System Has $4.30 Million Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Is Corcept Therapeutics Incorporated (HTD) stock a buy before new product rolloutEarnings Performance Report & Weekly High Return Stock Forecasts - Newser
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,000 Shares of Stock - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sean Maduck Sells 20,000 Shares - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $397,650.00 in Stock - MarketBeat
Will Corcept Therapeutics Incorporated (HTD) stock return to pre crash levelsMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Chief Development Officer At Corcept Therapeutics Sells $364K Of Stock - Benzinga
Is Corcept Therapeutics Incorporated (HTD) stock inflation resilient2025 Momentum Check & Fast Moving Stock Trade Plans - Newser
Shelton Capital Management Sells 125,365 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Bridge City Capital LLC Sells 22,487 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Insider Sold Shares Worth $1,590,490, According to a Recent SEC Filing - marketscreener.com
Corcept Therapeutics Insider Sold Shares Worth $3,190,796, According to a Recent SEC Filing - MarketScreener
Lyon of Corcept Therapeutics sells $397k in shares By Investing.com - Investing.com South Africa
Corcept Therapeutics exec William Guyer sells $1.6m in shares By Investing.com - Investing.com Canada
Officer Guyer Sells 20,000 ($1.6M) Of Corcept Therapeutics Inc [CORT] - TradingView
Lyon of Corcept Therapeutics sells $397k in shares - Investing.com
Corcept Therapeutics CEO Belanoff sells $3.19 million in stock By Investing.com - Investing.com Canada
Van Hulzen Asset Management LLC Purchases New Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
3 Growth Companies With High Insider Ownership Seeing 30% Revenue Growth - simplywall.st
Russell Investments Group Ltd. Has $13.67 Million Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Incorporated $CORT Shares Sold by SG Americas Securities LLC - MarketBeat
Officer Guyer Files To Sell 20,000 Of Corcept Therapeutics Inc [CORT] - TradingView
Corcept Therapeutics (CORT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will Corcept Therapeutics Incorporated (HTD) stock outperform global peers - Newser
Is Corcept Therapeutics Incorporated (HTD) stock undervalued at current priceMarket Risk Analysis & Low Risk Investment Opportunities - Newser
Will Korlym Continue to Drive Corcept's Top Line in 2026? - Yahoo Finance
Corcept Therapeutics Incorporated $CORT Shares Sold by Rhumbline Advisers - MarketBeat
F m Investments LLC Invests $1.61 Million in Corcept Therapeutics Incorporated $CORT - MarketBeat
Capital Fund Management S.A. Trims Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
19,858 Shares in Corcept Therapeutics Incorporated $CORT Acquired by XTX Topco Ltd - MarketBeat
Cushing’s Syndrome Diagnostics and Therapeutics Market, 2034 - Global Market Insights Inc.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Is Largely Controlled by Institutional Shareholders Who Own 69% of the Company - 富途牛牛
Legal & General Group Plc Boosts Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Zacks Research Analysts Decrease Earnings Estimates for CORT - MarketBeat
Franklin Resources Inc. Increases Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept (CORT) Q3 2025 Earnings Call Transcript - The Globe and Mail
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $364,050.00 in Stock - MarketBeat
Whale Trades: Will Corcept Therapeutics Incorporated stock deliver strong dividend growthJuly 2025 Chart Watch & Expert Approved Trade Ideas - moha.gov.vn
Chief Development Officer Of Corcept Therapeutics Sold $364K In Stock - Benzinga
What is Zacks Research's Forecast for CORT FY2025 Earnings? - MarketBeat
Corcept Therapeutics Incorporat (CORT) Stock Forecasts - Yahoo Finance
Aug PreEarnings: Can Corcept Therapeutics Incorporated stock sustain free cash flow growth2025 Breakouts & Breakdowns & AI Powered Trade Plan Recommendations - BỘ NỘI VỤ
Insider Sell: William Guyer Sells Shares of Corcept Therapeutics Inc (CORT) - GuruFocus
CORCEPT THERAPEUTICS' Chief Development Officer Sells Shares - TradingView
Officer Guyer Sells 4,500 ($364.1K) Of Corcept Therapeutics Inc [CORT] - TradingView
Corcept Therapeutics Incorporated (CORT) Modifies Revenue Guidance while Banking on Cushing Syndrome Treatment for Growth - Finviz
CORCEPT THERAPEUTICS INC (1CORT.MI) - Yahoo! Finance Canada
Corcept Therapeutics' (CORT) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Corcept Therapeutics IncorporatedCommon Stock (NQ: CORT - Markets Financial Content
HC Wainwright & Co. Reiterates Corcept Therapeutics (CORT) Buy Recommendation - Nasdaq
Operating cash flow per share of Corcept Therapeutics Incorporated. – LSE:0I3Q - TradingView
Shareholder Lake Bainwood Living Trust Guyer William Ttee Files To Sell 4,500 Of Corcept Therapeutics Inc [CORT] - TradingView
Corcept Therapeutics stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Canada
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):